Genoox vs Medial EarlySign
Genoox vs Medial EarlySign, compared side by side on 20 data points: what each one does, how big it is, what it has raised, the tech running each site, and what users report. We score both out of 100 on traction, team and visibility: Genoox is on 62/100 and Medial EarlySign on 49/100.
Where each one leads
Genoox
- our overall score: 62/100 against 49/100
- agent readiness: 38/100 against 22/100
- domain rating: 50/100 against 31/100
- headcount: 53 against 8
- headcount growth: +10.7% against -26.4%
- LinkedIn following: 3,902 against 2,122
Medial EarlySign
- funding raised: $50.0M against $20.0M
At a glance
| Measure | Genoox | Medial EarlySign |
|---|---|---|
| What it is | Genoox provides a cloud-based AI platform for genomic data analysis, connecting clinicians and healthcare organizations. | Develops AI-powered decision support tools for personalized medical data interpretation and prediction. |
| Category | Healthcare, Genomics, Genomic Data, Next Generation Sequencing | Healthcare, Decision Support, Insights, Detection |
| Sells toBusiness model | B2B | B2B |
| Offering | Software | Software |
| Founded | 2014 | 2009 |
| Headquarters | Palo Alto, United States | Tel Aviv, Israel |
| Status | Active | Inactive |
Size, funding and growth
| Measure | Genoox | Medial EarlySign |
|---|---|---|
| Employees | 53 | 8 |
| Headcount growthLast 12 months | +10.7% | -26.4% |
| Total funding | $20.0M | $50.0M |
| Latest round | Series C | Series B |
| LinkedIn followers | 3,902 | 2,122 |
StartupHub scores
Our own 0-100 ratings. They measure company strength and site quality, not which product suits you.
| Measure | Genoox | Medial EarlySign |
|---|---|---|
| StartupHub scoreOur 0-100 rating | 62/100 | 49/100 |
| Traction | 54/100 | 48/100 |
| Team | 70/100 | 20/100 |
| Community | 8/100 | 15/100 |
| Search visibility | 32/100 | 29/100 |
| Quality | 68/100 | 58/100 |
| Agent readinessHow well an AI agent can read and act on the site | F (38/100) | F (22/100) |
| Domain ratingLink authority, 0-100 | 50/100 | 31/100 |
Technology
Detected on each public site, so it reflects the marketing stack as well as the product.
| Measure | Genoox | Medial EarlySign |
|---|---|---|
| CDN | Cloudflare | Not detected |
| Frameworks | Angular | Not detected |
Genoox vs Medial EarlySign: common questions
Which is better, Genoox or Medial EarlySign?
On our 0-100 score Genoox rates higher (62/100 against 49/100). The score weights traction, team, visibility and profile completeness, so it reflects company strength rather than which product suits you. We compare the two on 20 data points above: read the rows that match what you are buying for.
How do Genoox and Medial EarlySign compare on the numbers?
Genoox leads on our overall score (62/100 against 49/100), agent readiness (38/100 against 22/100), domain rating (50/100 against 31/100), headcount (53 against 8), headcount growth (+10.7% against -26.4%), LinkedIn following (3,902 against 2,122). Medial EarlySign leads on funding raised ($50.0M against $20.0M).
Read the full Genoox review and pricing or the Medial EarlySign review and pricing. You can also browse other Genoox alternatives we track.